| Literature DB >> 35631207 |
Malak Kouiti1,2, Cristian Hernández-Muñiz1, Ibtissam Youlyouz-Marfak2, Inmaculada Salcedo-Bellido1,3,4, Juan Mozas-Moreno3,4,5,6, José Juan Jiménez-Moleón1,3,4.
Abstract
Several epidemiological studies have analyzed the effects of lifestyle modification on reducing the risk of gestational diabetes mellitus (GDM); however, their results remain inconsistent. This umbrella review aims to evaluate the effects of diet and/or physical activity interventions during pregnancy on preventing GDM. Systematic reviews and meta-analysis of randomized clinical trials reporting preventive effects of diet and/or physical activity in reducing the incidence of GDM were included from PubMed, Web of Science, Scopus and Cochrane library. Two authors independently assessed the overlapping and quality of the 35 selected reviews using AMSTAR 2. The results, although variable, tend to defend the protective role of diet and physical activity interventions separately and independently of each other in the prevention of GDM. However, the results for the combined interventions show a possible protective effect; however, it is not entirely clear because most of the analyzed meta-analyses tend to approach 1, and heterogeneity cannot be ruled out. Establishing conclusions about the most efficient type of intervention and a dose-effect relationship was not feasible given the low quality of systematic reviews (83% low to critically low) and the variability in reporting interventions. Therefore, more studies with better quality and definition of the interventions are required. The protocol was previously registered in PROSPERO as CRD42021237895.Entities:
Keywords: dietary intervention; experimental studies; gestational diabetes mellitus; meta-analysis; physical activity intervention; randomized controlled clinical trials; systematic reviews
Mesh:
Year: 2022 PMID: 35631207 PMCID: PMC9144260 DOI: 10.3390/nu14102066
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Flow chart: Systematic review selection process. RCTs: Randomized controlled trials; GDM: Gestational Diabetes Mellitus; and PA: Physical Activity.
Figure 2Accomplishment of systematic review with AMSTAR-2 items. (A) Critical items. (B) Non-critical items. Critical items: Item 2: Previous protocol review; Item 4: Adequate literature search; Item 7: Excluded studies justification; Item 9: Bias risk of individual studies included; Item 11: Appropriate meta-analysis methods; Item 13: Consideration of the bias risk in the interpretation of the review results; Item 15: Assessment of the presence and probable impact of publication bias. Non-critical items: Item 1: Research questions and inclusion criteria include PICO components; Item 3: Explaining decision about the study designs to include in the review; Item 5: Study selection performed in duplicate; Item 6: Data extraction performed in duplicate; Item 8: Describing included studies with sufficient detail; Item 10: Reporting the sources of funding for the studies included in the review; Item 12: Assessing the potential impact of bias risk on results; Item 14: Satisfactory explanation and discussing any observed heterogeneity in the review results; and Item 16: Potential sources of conflict including any funding received.
Overlapping between reviews.
| Overlapping | N | CCA | Classification |
|---|---|---|---|
|
| |||
| Reviews of RCTs with pregnant women in general published since 2015 | 11 | 26.28% | Very high |
| Reviews of RCTs with high-risk women published since 2015 | 6 | 19.26% | Very high |
| Reviews of RCTs with pregnant women in general published before 2015 | 3 | 37.5% | Very high |
|
| 4 | 25.39% | Very high |
|
| 5 | 36.49% | Very high |
(N = Number of reviews included in the overlapping assessment; CCA = Corrected Covered Area).
Systematic reviews finding including physical activity intervention in reducing GDM.
| Systematic Review ID | RCTs Number | Participant Included in Intervention and Control Group ( | Association Measurement | I2 ( | Quality (Amstar 2) | |
|---|---|---|---|---|---|---|
| Oostdam et al., 2011 [ | 3 | 125/113 | RD −0.05 (−0.20–0.10) | 66 (0.05) | Critically low | |
| Han et al., 2012 [ | 5 | 437/389 | RR 1.10 (0.66–1.84) | 0 (0.37) | Low | |
| Yin et al., 2014 [ | 5 | 497/450 | RR 0.91 (0.57–1.44) | 26 (0.25) | Critically low | |
| Russo et al., 2015 [ | 10 | 569/520 | RR 0.74 (0.57–0.97) | 12 (0.33) | Critically low | |
| Sanabria-Martínez et al., 2015 [ | 8 | N.A. | RR 0.69 (0.52–0.91) | 0 (0.61) | Critically low | |
| Madhuvrata et al., 2015 * [ | 3 | 76/76 | OR 0.77 (0.33–1.79) | 0 (0.53) | Moderate | |
| Aune et al., 2016 [ | 12 | 9804 ** | RR 0.69 (0.50–0.96) | 30.2 (0.15) | Critically low | |
| Song et al., 2016 [ | 10 | 4161 ** | RR 0.77 (0.54–1.09) | N.A. | Critically low | |
| Da Silva et al., 2017 [ | 10 | 1883/1907 | RR 0.67 (0.49–0.92) | 33 (0.14) | Critically low | |
| Zheng et al., 2017 [ | 7 | 550/563 | OR 0.62 (0.43–0.89) | 37 (0.19) | Critically low | |
| Ming et al., 2018 * [ | 9 | 1472/1509 | RR 0.58 (0.37–0.90) | 46 (0.07) | Low | |
| Davenport et al., 2018 [ | 27 | 7568/7198 | OR 0.62 (0.52–0.75) | 0 (0.51) | High | |
| Bennett et al., 2018 [ | 10 | 2981 ** | RR 0.62 (0.50–0.78) | 0 (0.90) | Moderate | |
| Yu et al., 2018 [ | 6 | 651/719 | RR 0.59 (0.39–0.88) | 46 (0.11) | Critically low | |
| Chatzakis et al., 2019 * [ | 14 | 575/589 | RR 0.80 (0.60–1.07) | 30 | Low | |
| Du et la., 2019 * [ | 13 | 550/572 | RR 0.71 (0.57–0.89) | 0 (0.52) | Low | |
| Makaruk et al., 2019 [ | 10 | 1747/2013 | N.A. | N.A. | Critically low | |
| Nasiri-Amiri et al., 2019 * [ | 8 | 727/714 | RR 0.76 (0.65–1.08) | 50 (0.05) | Critically low | |
| Guo et al., 2019 [ | 19 | 5883 ** | RR 0.70 (0.95–0.84) | N.A. | Critically low | |
| Doi et al., 2020 * [ | 11 | 722/745 | RR 0.69 (0.51–0.94) | 23.2 (0.02) | Low | |
* Population = women at high risk; ** Total sample size; N.A. = Not available; OR = odds ratio; RR = relative risk; RD = risk difference; N = exposed sample size; n = no exposed sample size; and I2(p) = heterogeneity test (p-value).
Figure 3Forest plot of association of lifestyle intervention in reducing the risk of GDM. (A) Physical activity intervention. (B) Diet intervention. (C) Mixed intervention. * Moderate to high-quality review; ⊦: Odds Ratio; and ⊧: Women at high risk.
Systematic reviews finding including diet intervention in reducing GDM.
| Systematic Review ID | RCTs Number | Participant Included in Intervention and Control Group ( | Association Measurement | I2 ( | Quality (Amstar 2) |
|---|---|---|---|---|---|
| Oostdam et al., 2011 [ | 7 | 449/364 | RD −0.05 (−0.10–−0.01) | 41 (0.12) | Critically low |
| Madhuvrata et al., 2015 * [ | 3 | 202/207 | OR 0.33 (0.14–0.76) | 26 (0.26) | Moderate |
| Rogozińska et al., 2015 [ | 6 | 725/754 | RR 0.67 (0.38–1.15) | 52 (0.06) | Moderate |
| Song et al., 2016 [ | 5 | 1279 ** | RR 0.80 (0.58–1.10) | - | Critically low |
| Tieu et al., 2017 [ | 11 | 628/652 | RR 0.60 (0.35–1.04) | 56 (0.07) | High |
| Bennett et al., 2018 [ | 9 | 3388 ** | RR 0.56 (0.36–0.87) | 53 (0.03) | Moderate |
| Lamminpää et al., 2018 [ | 15 | N.A. | N.A. | N.A. | Critically low |
| Guo et al., 2019 [ | 11 | 2838 ** | RR 0.75 (0.59–0.95) | N.A. | Critically low |
| Zhang et al., 2020 *** [ | 2 | 911/937 | OR 0.66 (0.52–0.82) | 0 (0.85) | Critically low |
* Population = women at high risk; ** Total sample size; *** Mediterranean diet; N.A. = Not available; OR = odds ratio; RR = relative risk; N = exposed simple size; n = no exposed simple size; and I2(p) = heterogeneity test (p-value).
Systematic reviews finding including mixed intervention in reducing GDM.
| Study ID | RCTs Number | Participant Included in Intervention and Control Group ( | Association Measurement | I2( | Quality |
|---|---|---|---|---|---|
| Bain et al., 2015 [ | 13 | 1903/1841 | RR 0.92 (0.68–1.23) | 43.13 (0.06) | Low |
| Madhuvrata et al., 2015 * [ | 6 | 562/526 | OR 1.44 (0.96–2.14) | 0 (0.93) | Moderate |
| Rogozińska et al., 2015 [ | 12 | 2399/2346 | RR 0.95 (0.76–1.18) | 23 (0.21) | Moderate |
| Song et al., 2016 [ | 14 | 6047 ** | RR 0.85 (0.70–1.03) | N.A. | Critically low |
| Shepherd et al., 2017 [ | 19 | 3353/3280 | RR 0.85 (0.71–1.01) | 42 (0.03) | High |
| Davenport et al., 2018 [ | 22 | 575/550 | OR 0.90 (0.74–1.10) | 30 (0.09) | High |
| Bennett et al., 2018 [ | 22 | 7274 ** | RR 0.90 (0.77–1.05) | 33 (0.072) | Moderate |
| Guo et al., 2019 [ | 18 | 7024 ** | RR 0.86 (0.71–1.04) | N.A. | Critically low |
* Population = women at high risk; ** Total sample size; N.A. = Not available; OR = odds ratio; RR = relative risk; N = exposed simple size; n = no exposed simple size; and I2(p) = heterogeneity test (p-value).
Systematic reviews finding including GDM as a secondary outcome.
| Systematic Reviews with GDM as Not the Principal Outcome | |||||
|---|---|---|---|---|---|
| RCTs Number | Participant Included in Intervention and Control Group ( | Association Measurement | I2 ( | Quality (Amstar 2) | |
|
| |||||
| Magro-Malosso et al., 2017 * [ | 7 | 623/727 | RR 0.61 (0.41–0.90) | - | Critically low |
| Díaz-Burrueco et al., 2021 [ | 5 | 782/1091 | OR 0.68 (0.39–1.19) | - | Low |
|
| |||||
| Thangaratinam et al., 2012 [ | 3 | 409 ** | RR 0.39 (0.23–0.69) | 21 (0.001) | Critically Low |
|
| |||||
| Rogozinska et al., 2017 [ | 31 | 5710/5408 | OR 0.77 (0.63–0.94) | 38 (0.02) | Low |
| O’brien et al., 2016 [ | 2 | 243 ** | RR 1.02 (0.41–2.57) | - | Critically Low |
| Thangaratinam et al., 2012 [ | 6 | 1233 ** | RR 1.18 (0.78–1.77) | 0 (0.44) | Critically Low |
| Oteng-Ntim Et al., 2012 * [ | 6 | 526/491 | OR 0.80 (0.58–1.10) | 62 (0.002) | Critically Low |
(* Pregnant women at high risk; and ** Total sample size).